慢阻肺的临床评估与稳定期的管理精编PPT课件.pptVIP

磷酸二酯酶-4 (PDE-4)抑制剂，机制： 通过抑制细胞内的环磷酸腺苷的降解来减轻炎症。 茶碱静脉给药主要应用于重、危症哮喘 * According to 慢阻肺 2007, 慢阻肺 treatment has the goal as above. Most patients see doctors aiming to relieve symptoms, which can be achieved in short term by pharmacological therapy. Beyond this, based on the nature of 慢阻肺, the long term success via medication should be “impacting clinical course” and then prevent disease progression. But up to now, there is no existing medications proven to be able to slow the lung-function decline ( embodied by FEV1 decline rate) that is the hallmark of 慢阻肺. 根据2007年GOLD指南，慢阻肺的治疗具有以上目标。绝大数病人去看医生